chr5-150396792-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001371623.1(TCOF1):āc.4295G>Cā(p.Gly1432Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0214 in 1,610,616 control chromosomes in the GnomAD database, including 444 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001371623.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCOF1 | NM_001371623.1 | c.4295G>C | p.Gly1432Ala | missense_variant | 24/27 | ENST00000643257.2 | NP_001358552.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCOF1 | ENST00000643257.2 | c.4295G>C | p.Gly1432Ala | missense_variant | 24/27 | NM_001371623.1 | ENSP00000493815 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0178 AC: 2710AN: 152014Hom.: 43 Cov.: 31
GnomAD3 exomes AF: 0.0185 AC: 4478AN: 242024Hom.: 44 AF XY: 0.0189 AC XY: 2489AN XY: 131640
GnomAD4 exome AF: 0.0217 AC: 31697AN: 1458484Hom.: 401 Cov.: 33 AF XY: 0.0216 AC XY: 15635AN XY: 725228
GnomAD4 genome AF: 0.0178 AC: 2711AN: 152132Hom.: 43 Cov.: 31 AF XY: 0.0182 AC XY: 1351AN XY: 74378
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Benign - Stand Alone. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >3% in Exome Aggregation Consortium (European non-Finnish population). - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 14, 2018 | - - |
Treacher Collins syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at